A. Evans

Brett Hemamali David J. Andrew J. Daniel M. Chin-Chen Gl Delahunt Samaratunga Grignon Evans Berney P, G. Litjens, J. A. van der Laak, 2020, Modern Pathology.

Issues and challenges associated with classifying neoplasms in percutaneous needle biopsies of incidentally found small renal masses.

B. Delahunt, A. Evans, J. Srigley, 2015, Seminars in diagnostic pathology.

An overview of recent WHO classification and AJCC pTNM staging changes for testicular neoplasms and their impact on the handling and reporting of orchidectomy specimens

A. Evans, 2018, Diagnostic Histopathology.

Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue

A. Evans, T. H. van der Kwast, N. Lawrentschuk, 2012, Journal of Clinical Pathology.

Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progression.

A. Evans, T. H. van der Kwast, A. Zlotta, 2014, The Journal of urology.

Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses.

A. Evans, A. Finelli, M. Jewett, 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.

A. Evans, T. H. van der Kwast, A. Zlotta, 2010, The Journal of urology.

Use of whole slide imaging (WSI) for distance teaching

A. Evans, R. Chetty, N. Depeiza, 2020, Journal of Clinical Pathology.

Uncommon tumours in the adult bladder: rare entities with recognized diagnostic pitfalls

A. Evans, B. Dickson, 2013 .

Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.

Danny Vesprini, John Trachtenberg, William Chu, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomies

A. Evans, J. Squire, A. Joshua, 2011, The Prostate.

Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumors.

A. Evans, J. Srigley, J. Sweet, 2017, Pathology, research and practice.

Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications

A. Evans, P. Henry, 2009, Journal of Clinical Pathology.

Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.

A. Evans, P. Black, F. Saad, 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Effect of healthcare provider characteristics on nodal yield at radical cystectomy.

A. Evans, J. Trachtenberg, G. Lockwood, 2008, Urology.

Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy.

A. Evans, A. Finelli, K. Jhaveri, 2016, European urology.

Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide.

Robert A Weersink, Brian C Wilson, Masoom A Haider, 2007, Radiology.

Guidelines from the Canadian Association of Pathologists for establishing a telepathology service for anatomic pathology using whole-slide imaging

Amin Kabani, Andrew Evans, A. Evans, 2014, Journal of pathology informatics.

Preneoplasia in the prostate gland with emphasis on high grade prostatic intraepithelial neoplasia

A. Evans, J. Srigley, J. Merrimen, 2013, Pathology.

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease

Rodolfo Montironi, Brett Delahunt, Cristina Magi-Galluzzi, 2011, Modern Pathology.

Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity

A. Evans, J. Srigley, Michael W Curtis, 2005, Modern Pathology.

Large Cell Neuroendocrine Carcinoma of Prostate: A Clinicopathologic Summary of 7 Cases of a Rare Manifestation of Advanced Prostate Cancer

A. Evans, P. Humphrey, T. H. van der Kwast, 2006, The American journal of surgical pathology.

Prostate cancer as a model system for genetic diversity in tumors.

A. Evans, J. Squire, P. Park, 2011, Advances in cancer research.

Prostatic preneoplasia and beyond.

A. Chinnaiyan, A. Evans, J. Squire, 2008, Biochimica et biophysica acta.

Primary Paratesticular Osteosarcoma: Case Report and A Review of the Literature

A. Evans, R. Chetty, M. Al-Shraim, 2007, TheScientificWorldJournal.

PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications

Paulo A. S. Nuin, A. Evans, O. Ludkovski, 2012, Genes, chromosomes & cancer.

TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair

A. Evans, T. H. van der Kwast, J. Srigley, 2013, Clinical Cancer Research.

Radiotherapy : Implications for Fusion Status and DSB Repair Status Is Not Prognostic Following Prostate Cancer

A. Evans, J. Srigley, W. Lam, 2013 .

Predictive Biomarkers and Personalized Medicine TMPRSS2-ERG Status Is Not Prognostic Following Prostate CancerRadiotherapy: Implications forFusionStatusandDSB Repair

A. Evans, J. Srigley, W. Lam, 2013 .

Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.

A. Evans, J. Squire, J. Bayani, 2006, Neoplasia.

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215

A. Evans, J. Grigull, G. Yousef, 2011, British Journal of Cancer.

Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction.

A. Evans, G. Pond, B. Gallie, 2004, The American journal of pathology.

PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy

A. Evans, R. Bristow, K. Luoto, 2011, Clinical Cancer Research.

PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade

A. Evans, K. Song, K. Ding, 2013, Modern Pathology.

Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias.

Paulo A. S. Nuin, A. Evans, J. Squire, 2006, Cancer Genetics and Cytogenetics.

The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into genome-wide signature of preneoplasia associated with cancer progression

A. Evans, R. Houlston, J. Squire, 2006, BMC Genomics.

Integrated Pathology Informatics Enables High-Quality Personalized and Precision Medicine: Digital Pathology and Beyond.

Zoya I. Volynskaya, Zoya Volynskaya, Andrew Evans, 2017, Archives of pathology & laboratory medicine.

Statin use and time to progression in men on active surveillance for prostate cancer

A. Evans, A. Zlotta, A. Finelli, 2018, Prostate Cancer and Prostatic Diseases.

Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.

B. Delahunt, A. Evans, J. Kench, 2019, Pathology.

Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer

Ellery Wulczyn, Yun Liu, Niels Olson, 2018, npj Digital Medicine.

Hematologic Parameters to Predict Small Renal Mass Biopsy Pathology.

A. Evans, A. Finelli, M. Jewett, 2016, Clinical genitourinary cancer.

Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.

A. Evans, T. H. van der Kwast, Z. Cohen, 2013, European urology.

Gleason grading: past, present and future

Brett Delahunt, B. Delahunt, A. Evans, 2012, Histopathology.

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

Po-Hsuan Cameron Chen, David F. Steiner, G. Corrado, 2022, Nature Medicine.

Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists

Daan Nieboer, Liang Cheng, Lars Egevad, 2016, Histopathology.

Percutaneous renal tumour biopsy

B. Delahunt, A. Evans, H. Samaratunga, 2014, Histopathology.

α-Methylacyl CoA racemase (P504S): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies

A. Evans, 2003, Journal of clinical pathology.

MicroRNA‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma

A. Evans, G. Yousef, A. Scorilas, 2016, Cancer medicine.

An integrated genomic analysis of papillary renal cell carcinoma type 1 uncovers the role of focal adhesion and extracellular matrix pathways

A. Evans, G. Yousef, A. Finelli, 2015, Molecular oncology.

Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy.

Michael A S Jewett, A. Evans, M. Jewett, 2007, The Journal of urology.

The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins

A. Evans, T. H. van der Kwast, Gangyong Li, 2012, Journal of Clinical Pathology.

SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion

A. Evans, B. Donnelly, T. Bismar, 2017, Pathology & Oncology Research.

Interobserver Variability Between Expert Urologic Pathologists for Extraprostatic Extension and Surgical Margin Status in Radical Prostatectomy Specimens

Madeleine Moussa, Andrew J. Evans, David G. Bostwick, 2008, The American journal of surgical pathology.

Clinical significance of the positive surgical margin based upon location, grade, and stage.

A. Evans, A. Zlotta, N. Lawrentschuk, 2010, Urologic oncology.

Slow-growing pituitary metastasis from renal cell carcinoma: literature review.

A. Evans, R. Moon, W. Singleton, 2020, World neurosurgery.

Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma

A. Evans, G. Yousef, A. Scorilas, 2014, Molecular Cancer.

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist

M. Rubin, A. Chinnaiyan, B. Delahunt, 2014, Virchows Archiv.

Review of the current state of whole slide imaging in pathology

John D. Pfeifer, Liron Pantanowitz, Andrew J. Evans, 2011, Journal of pathology informatics.

Accurate molecular classification of kidney cancer subtypes using microRNA signature.

George M Yousef, Jörg Grigull, Andrew Evans, 2011, European urology.

The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomy.

A. Evans, A. Zlotta, A. Finelli, 2014, The Journal of urology.

Serological Markers for the Detection of Prostate Cancer Comprehensive Assessment of Candidate Genes

A. Evans, J. Trachtenberg, S. Narod, 2003 .

Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients.

A. Evans, A. Finelli, Y. Pei, 2011, The Journal of urology.

Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.

A. Evans, T. H. van der Kwast, J. Trachtenberg, 2015, European urology.

Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine

A. Evans, J. Moffat, K. Brown, 2016, BMC Cancer.

Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.

A. Evans, G. Yousef, J. Bartlett, 2016, European urology focus.

S100A11 is a potential prognostic marker for clear cell renal cell carcinoma

A. Evans, G. Yousef, A. Scorilas, 2015, Clinical & Experimental Metastasis.

Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (ICCR)

B. Delahunt, A. Evans, J. Srigley, 2019, Histopathology.

Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.

A. Evans, M. Gleave, M. Haider, 2020, European urology.

Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline.

A. Evans, W. Lowrance, Nofisat Ismaila, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Canadian guidelines for the management of small renal masses (SRM).

Pierre I Karakiewicz, Ronald B. Moore, Simon Tanguay, 2015, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Active surveillance of small renal masses: progression patterns of early stage kidney cancer.

A. Evans, M. Gleave, B. Gallie, 2011, European urology.

Long‐term oncological outcomes of patients with paratesticular sarcoma

A. Evans, B. Dickson, C. Catton, 2019, BJU international.

Variant Histology and Clinicopathological Features of Prostate Cancer in Men Younger than 50 Years Treated with Radical Prostatectomy

A. Evans, T. H. van der Kwast, N. Fleshner, 2017, The Journal of urology.

Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: observations on DNA, RNA, protein extractions and VHL mutation detection.

A. Evans, B. Gallie, A. Finelli, 2012, Pathology, research and practice.

Dataset for the reporting of renal biopsy for tumour: recommendations from the International Collaboration on Cancer Reporting (ICCR)

B. Delahunt, A. Evans, J. Srigley, 2019, Journal of Clinical Pathology.

Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis

A. Evans, G. Yousef, J. Bartlett, 2017, The American journal of surgical pathology.

Accuracy of renal tumour biopsy for the diagnosis and subtyping of papillary renal cell carcinoma: analysis of paired biopsy and nephrectomy specimens with focus on discordant cases

A. Evans, T. H. van der Kwast, C. Cheung, 2019, Journal of Clinical Pathology.

Desmoplastic Small Round Cell Tumor Presenting as an Isolated Testicular Mass in an Adult With Multiple Previous Malignancies.

A. Evans, B. Dickson, A. Razak, 2016, Clinical genitourinary cancer.

An Increase in Gleason 6 Tumor Volume While on Active Surveillance Portends a Greater Risk of Grade Reclassification with Further Followup.

A. Evans, A. Zlotta, A. Finelli, 2016, The Journal of urology.

Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates.

A. Evans, T. H. van der Kwast, J. Trachtenberg, 2015, The Journal of urology.

Pathologic Quiz Case A 44-Year-Old Woman With an Incidental Asymptomatic Renal Mass

A. Evans, K. Aljerian, 2004 .

Pathologic quiz case: a 44-year-old woman with an incidental asymptomatic renal mass. Atypical epithelioid angiomyolipoma.

A. Evans, K. Aljerian, 2004, Archives of pathology & laboratory medicine.

Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance

A. Evans, T. H. van der Kwast, J. Trachtenberg, 2017, The Journal of urology.

A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization

A. Evans, G. Yousef, E. Diamandis, 2017, Oncotarget.

Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer.

A. Evans, F. Moraes, A. Berlin, 2019, European urology oncology.

Variants of urothelial carcinoma apart from those with glandular, squamous or neuroendocrine differentiation: key morphologic features, differential diagnoses and prognostic significance

A. Evans, M. Downes, 2013 .

Primary large cell neuroendocrine carcinoma of the urinary bladder.

A. Evans, J. Tsihlias, W. Chapman, 2002, Archives of pathology & laboratory medicine.

Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience.

A. Evans, A. Finelli, M. Jewett, 2008, The Journal of urology.

Treatment effects in prostate cancer

A. Evans, 2018, Modern Pathology.

Low‐grade prostate cancer should still be labelled cancer

B. Delahunt, D. Berney, D. Bostwick, 2022, BJU international.

Utility of Pathology Imagebase for standardisation of prostate cancer grading

Toyonori Tsuzuki, Lars Egevad, Murali Varma, 2018, Histopathology.

Imaging features of primary malignant rhabdoid tumour of the brain

A. Evans, R. Ganatra, S. Morris, 2001, Pediatric Radiology.

Combined pleomorphic xanthoastrocytoma-ganglioglioma of the cerebellum.

A. Evans, J. Bilbao, M. Cusimano, 2000, Archives of pathology & laboratory medicine.

Combined T 2 and Diffusion Weighted MRI for Localization of Prostate Cancer

A. Evans, J. Trachtenberg, M. Haider, 2007 .

Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience.

A. Evans, A. Zlotta, T. Hermanns, 2015, European urology.

Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified.

Antonio Finelli, Andrew Evans, Michael A S Jewett, 2016, The Journal of urology.

Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.

A. Evans, R. Weersink, B. Wilson, 2007, The Journal of urology.

Recurrent Pleural and Pericardium Effusions in a White Woman With IgG4-related Syndrome

A. Evans, J. Epstein, 2009 .

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

P. Ström, H. Olsson, B. Delahunt, 2020, Virchows Archiv.

Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy.

A. Evans, T. H. van der Kwast, J. Trachtenberg, 2016, Urology.

American Telemedicine Association clinical guidelines for telepathology

Elizabeth A. Krupinski, Liron Pantanowitz, Lewis A. Hassell, 2014, Journal of pathology informatics.

Prostate cancer grading, time to go back to the future

B. Delahunt, D. Bostwick, A. Evans, 2020, BJU international.

One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading.

B. Delahunt, A. Evans, H. Samaratunga, 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

International Telepathology: Promises and Pitfalls

Liron Pantanowitz, Andrew J. Evans, Michael Riben, 2016, Pathobiology.

Utility of whole slide imaging and virtual microscopy in prostate pathology

Lars Egevad, Ferran Algaba, Liliane Boccon-Gibod, 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: the University Health Network experience.

Tim-Rasmus Kiehl, A. Evans, T. Kiehl, 2009, Human pathology.

Clinical Applications of Whole-slide Imaging in Anatomic Pathology

Zoya I. Volynskaya, Zoya Volynskaya, A. Evans, 2017, Advances in anatomic pathology.

Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?

A. Evans, T. H. van der Kwast, M. Haider, 2020, The Journal of urology.

Measurement of peri‐prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer

A. Evans, T. H. van der Kwast, G. Lockwood, 2012, BJU international.

Active surveillance for the management of localized prostate cancer: Guideline recommendations.

A. Evans, J. Srigley, C. Morash, 2015, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Active Surveillance for the Management of Localized Prostate Cancer

A. Evans, J. Srigley, C. Morash, 2015 .

Supervised and unsupervised methods for prostate cancer segmentation with multispectral MRI.

Yongyi Yang, Xin Liu, Miles N Wernick, 2010, Medical physics.

Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate Biopsies

Rodolfo Montironi, Antonio Finelli, Lukas Bubendorf, 2010, The American journal of surgical pathology.

Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial.

A. Evans, M. Lucia, S. Taneja, 2007, Contemporary clinical trials.

Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort

Nathan Lawrentschuk, Theodorus H van der Kwast, Antonio Finelli, 2011, BJU international.

The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.

A. Evans, T. H. van der Kwast, J. Trachtenberg, 2014, Urology.

Prostate Cancers Scored as Gleason 6 on Prostate Biopsy are Frequently Gleason 7 Tumors at Radical Prostatectomy: Implication on Outcome

Murray Krahn, John Trachtenberg, Jehonathan H. Pinthus, 2006 .

Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome.

A. Evans, J. Trachtenberg, N. Fleshner, 2006, The Journal of urology.

Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?

A. Evans, T. H. van der Kwast, A. Zlotta, 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.

A. Evans, M. Harisinghani, K. Jhaveri, 2015, AJR. American journal of roentgenology.

Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading

Andrew J. Evans, Lars Egevad, Matthias Schwenkglenks, 2011, Virchows Archiv.

Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.

B. Delahunt, A. Evans, D. Grignon, 2017, Archives of pathology & laboratory medicine.

Predictive Value of In Vivo MR Spectroscopy With Semilocalization by Adiabatic Selective Refocusing in Differentiating Clear Cell Renal Cell Carcinoma From Other Subtypes.

A. Evans, A. Finelli, K. Jhaveri, 2020, AJR. American journal of roentgenology.

Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi‐institutional study

A. Evans, T. H. van der Kwast, E. Messing, 2011, BJU international.

Single Prostatic Cancer Foci on Prostate Biopsy

Monique J. Roobol, Andrew Evans, A. Evans, 2008 .

Establishment of a remote diagnostic histopathology service using whole slide imaging (digital pathology)

Andrew John Evans, Rajkumar Vajpeyi, Michele Henry, 2020, Journal of Clinical Pathology.

The Importance of eSlide Macro Images for Primary Diagnosis with Whole Slide Imaging

Liron Pantanowitz, Andrew J. Evans, J. Mark Tuthill, 2018, Journal of pathology informatics.

A multisite validation of whole slide imaging for primary diagnosis using standardized data collection and analysis

Michael C. Montalto, Anil Parwani, Jonhan Ho, 2016, Journal of pathology informatics.

Cystic renal cell carcinomas: do they grow, metastasize, or recur?

A. Evans, K. Jhaveri, H. Moshonov, 2013, AJR. American journal of roentgenology.

10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients.

Jette Borg, Andrew Evans, A. Evans, 2011, International journal of radiation oncology, biology, physics.

Operator is an independent predictor of detecting prostate cancer at transrectal ultrasound guided prostate biopsy.

A. Evans, G. Lockwood, N. Lawrentschuk, 2009, The Journal of urology.

Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer.

A. Evans, T. H. van der Kwast, J. Trachtenberg, 2011, European urology.

Clinical predictors of gleason score upgrading

A. Evans, J. Trachtenberg, G. Lockwood, 2007, Cancer.

Prostate Cancer Localization With Multispectral MRI Using Cost-Sensitive Support Vector Machines and Conditional Random Fields

Masoom A. Haider, Imam Samil Yetik, Yongyi Yang, 2010, IEEE Transactions on Image Processing.

Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada.

A. Evans, M. Gleave, B. Gallie, 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.

A. Evans, T. Pugh, Ugljesa Djuric, 2020, JCO Clinical Cancer Informatics.

Pathological predictors for site of local recurrence after radiotherapy for prostate cancer.

A. Evans, C. Ménard, M. Haider, 2012, International journal of radiation oncology, biology, physics.

690 NERVE-SPARING RADICAL PROSTATECTOMY IN SELECTED HIGH-RISK AND LOCALLY ADVANCED PROSTATE CANCERS IS ASSOCIATED WITH LOW POSITIVE MARGIN RATES USING A COMBINATION OF PREOPERATIVE MRI, SPECIAL INSTRUMENTATION AND INTRA-OPERATIVE FROZEN SECTIONS

A. Evans, N. Lawrentschuk, P. Boström, 2010 .

Systematic lateral prostate biopsy--are the benefits worth the costs?

A. Evans, G. Lockwood, A. Toi, 2008, The Journal of urology.

Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: the University Health Network experience.

Tim-Rasmus Kiehl, A. Evans, T. Kiehl, 2009, Seminars in diagnostic pathology.

ACTIVE SURVEILLANCE OF SMALL RENAL MASSES: A PROSPECTIVE MULTI-CENTER CANADIAN URO-ONCOLOGY GROUP TRIAL

A. Evans, M. Gleave, B. Gallie, 2009 .

Results of a surgically derived nomogram to predict Gleason score upgrading applied to a cohort of patients with "favorable-risk" prostate cancer treated with permanent seed brachytherapy.

A. Evans, C. Catton, A. Finelli, 2012, Urology.

2014 American Telemedicine Association clinical guidelines for telepathology: Another important step in support of increased adoption of telepathology for patient care

Elizabeth A. Krupinski, Liron Pantanowitz, Andrew J. Evans, 2015, Journal of pathology informatics.

Incidental detection of an aortic valve papillary fibroelastoma by echocardiography in an asymptomatic patient presenting with hypertension.

A. Evans, J. Butany, T. David, 1997, The Canadian journal of cardiology.

Pathologist-Level Grading of Prostate Biopsies with Artificial Intelligence pdf

Ming Zhou, Toyonori Tsuzuki, Pekka Ruusuvuori, 2019, ArXiv.

ISUP Consensus Definition of Cribriform Pattern Prostate Cancer

B. Delahunt, D. Berney, A. Evans, 2021, The American journal of surgical pathology.

Prostate cancer localization with multispectral MRI based on Relevance Vector Machines

Masoom A. Haider, Imam Samil Yetik, Miles N. Wernick, 2009, 2009 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

Evidence for a biopsy derived grade artifact among larger prostate glands.

A. Evans, J. Trachtenberg, G. Lockwood, 2006, The Journal of urology.

MP62-08 PATIENTS THAT DEMONSTRATE GLEASON 6 VOLUME PROGRESSION ON ACTIVE SURVEILLANCE HAVE A SUBSTANTIALLY GREATER RISK OF GRADE PROGRESSION ON FURTHER FOLLOW-UP

A. Evans, A. Zlotta, A. Finelli, 2014 .

Pathology Imagebase—a reference image database for standardization of pathology

Lars Egevad, Mark Clements, James G Kench, 2017, Histopathology.

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry

K. D. Sørensen, Ali Amin Al Olama, H. Ostrer, 2019, Nature Communications.

Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue

A. Evans, T. H. van der Kwast, N. Lawrentschuk, 2012, Journal of Clinical Pathology.

Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly.

A. Evans, T. H. van der Kwast, J. Trachtenberg, 2014, European urology.

M. Rubin, A. Chinnaiyan, B. Delahunt, 2014, Archives of pathology & laboratory medicine.

An Increase in Gleason 6 Tumor Volume While on Active Surveillance Portends a Greater Risk of Grade Reclassification with Further Followup.

A. Evans, A. Zlotta, A. Finelli, 2016, The Journal of urology.

Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma

A. Evans, T. H. van der Kwast, A. Zlotta, 2013, Journal of Clinical Pathology.

Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submission.

B. Delahunt, A. Evans, H. Samaratunga, 2014, Pathology.

Perineural invasion on prostate biopsy does not predict adverse pathological outcome.

A. Evans, T. H. van der Kwast, J. Trachtenberg, 2012, The Canadian journal of urology.

Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort.

A. Evans, T. H. van der Kwast, A. Zlotta, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.